Read More Pharma Industry News Bone Biologics files new U.S. patent for NELL-1-based bone regeneration in spinal fusion Bone Biologics files U.S. patent for rhNELL-1 bone regeneration in spine fusion, expanding IP ahead of clinical development. Learn what it means for investors. byPallavi MadhirajuJune 30, 2025